Exin Therapeutics
YC W25San Francisco, US · Founded 2024 · 9 employees · 1 known investors
Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease. The company trains machine learning models on proprietary multimodal neuroscience data to guide its therapeutic screening process.
Founders & leadership· Y Combinator alumni (W25)
Gabriel Ocana Santeroin𝕏Founder
Marko Tvrdicin𝕏Founder
Investors · 1
In the news
- US-based biotech firm cues P1.45-B investment in the Philippinesbusiness.inquirer.net · 2025
- US neurotherapeutics lab to operate in PH | The Manila Timesmanilatimes.net · 2025
- First Philippine neurotherapeutics laboratory gets green lane certificate - Manila Standardmanilastandard.net · 2025
- Manila Bulletin - AI biotech Exin Therapeutics plans ₱1-billion Philippine expansionmb.com.ph · 2025
- Exin Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2025